Entities / Person
Anne Wojcicki.
American biotech analyst, biologist, businesswoman, and co-founder of 23andMe
- Reports this week
- 0
- Active events
- 0
- Connections
- 7
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Anne Wojcicki uses her nonprofit to acquire 23andMe amidst a lawsuit led by Letitia James regarding genetic data privacy, while TTAM submitted a higher unsolicited offer than Regeneron.Speculative1 report1 development inside
-
Anne Wojcicki's board includes experts such as Alexis Battle.Some support1 report
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Anne Wojcicki this week
News at the entities that move Anne Wojcicki most-
Rob Bonta OperationalRob Bonta announced a settlement regarding the bankruptcy of 23andMe.Moves Anne Wojcicki
Connections
The 5 strongest of 7, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Michael Brin Structural
The two entities shared a formal, committed partnership through marriage.
-
TTAM Research Institute Structural
Anne Wojcicki founded, controls, and leads TTAM Research Institute.
-
23andMe Structural
Anne Wojcicki is the co-founder and key controller of 23andMe, having regained control through a buyout bid.
-
Rob Bonta Operational
Rob Bonta actively opposed 23andMe, the company associated with Anne Wojcicki, regarding privacy rights.
-
Alexis Battle Structural
Alexis Battle serves as an expert on a board related to Anne Wojcicki's professional sphere.
History
Events by the month they beganOctober 2026
1 eventJune 2026
2 events- Anne Wojcicki uses her nonprofit to acquire 23andMe amidst a lawsuit led by Letitia James regarding genetic data privacy, while TTAM submitted a higher unsolicited offer than Regeneron.
- TTAM Research Institute acquired 23andMe assets for $305m, ensuring a public good mission, and Anne Wojcicki regained control.